|
|
Volumn 356, Issue 9225, 2000, Pages
|
|
PEP trial. Pulmonary Embolism Prevention.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
FIBRINOLYTIC AGENT;
LOW MOLECULAR WEIGHT HEPARIN;
PLACEBO;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THROMBOXANE A2;
VASOCONSTRICTOR AGENT;
HIP FRACTURE;
HUMAN;
LETTER;
LUNG EMBOLISM;
META ANALYSIS;
POSTOPERATIVE HEMORRHAGE;
RISK FACTOR;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
ANIMAL;
CAUSE OF DEATH;
DISEASE MODEL;
DRUG ANTAGONISM;
ASPIRIN;
FIBRINOLYTIC AGENTS;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HIP FRACTURES;
HUMANS;
META-ANALYSIS;
PLATELET AGGREGATION INHIBITORS;
POSTOPERATIVE HEMORRHAGE;
PULMONARY EMBOLISM;
RISK FACTORS;
THROMBOEMBOLISM;
VENOUS THROMBOSIS;
PLACEBOS;
ANIMALS;
CAUSE OF DEATH;
CYCLOOXYGENASE INHIBITORS;
DISEASE MODELS, ANIMAL;
THROMBOXANE A2;
VASOCONSTRICTOR AGENTS;
|
|
EID: 0034660951
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)74494-9 Document Type: Letter |
|
Times cited : (8)
|
|
References (0)
|
